Orphazyme A/S Orphazyme A/S

Orphazyme A/S

ORPHA

Rangering i aksjer #3639
Orphazyme A/S currently conducts no significant business operations.... Orphazyme A/S currently conducts no significant business operations. Previously, the firm specialized in developing therapeutic solutions for rare neurodegenerative conditions. Established in 2009, its corporate headquarters are situated in Copenhagen, Denmark.
Aksjekurs
$133.39
Sist synkronisert: 2024-11-19
Markedsverdi
$4.66B
Endring (1 dag)
-0.13%
Endring (1 år)
0.00%
Land
DK
Handel Orphazyme A/S (ORPHA)

Kategori

Healthcare
Utbytteavkastning for Orphazyme A/S (ORPHA)
Orphazyme A/S (aksjesymbol: ORPHA) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Orphazyme A/S (ORPHA) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.17%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL